The European Association of Urology, along with other organisations representing professionals who treat prostate cancer, has published a “Cheat Sheet” summarising official guidelines on the treatment of prostate cancer.

Radiotherapy is a standard prostate cancer treatment option that offers outcomes comparable to surgery, particularly for localised disease. However, traditional radiotherapy schedules typically span several weeks, which can be burdensome for patients and put pressure on healthcare structures and radiotherapy capacity.

A recent Swedish study confirms that delivering precision radiotherapy over just two and a half weeks is equally successful as the standard eight-week approach. A decade after treatment, both options produced similar disease control rates and survival, says the study, first presented at this year’s congress of the European Society for Radiotherapy and Oncology.

Read the article here.

The updated 2025 EAU Prostate Cancer Guidelines contain important changes regarding diagnosis and localised disease.In this video, Giancarlo Marra talks to Phil Cornford about the key changes

In another video, Dr Marra talks to Derya Tilki about guideline updates regarding high-risk and locally advanced cancer and biochemical recurrence.

You can read our Annual Report 2024/25 here.

Prostate cancer affects partners and caregivers, as well as those receiving treatment. What can be done to help them?

Europa Uomo carried out an innovative study looking at the experiences of partners of men with prostate cancer and the physical and psychological burdens the disease imposes on them.

You can read more and download a full booklet about the EU-ProPER research here.

The Gladiator Association in Poland, a Europa Uomo member, took part in the annual “Welcome Summer in Bielany” picnic in Warsaw, meeting and talking to men about about the importance of prevention and a positive attitude.

“More and more young people are becoming interested in the topic of prevention,” said Gladiator Board member Marta Bogucka, “so we will do everything we can to reach as many people as possible – both the younger and older generations.”

Prostate cancer is set to become the most common cancer in men in an increasing number of countries over the next 20-30 years. Many more men will suffer and die unnecessarily from this disease.

A policy report launched by Global Action on Men’s Health calls for a new Global Prostate Cancer Initiative. It required  political will and commitment based on a recognition that men’s (and their families) cancer outcomes matter.

The European Patients’ Forum (EPF) has developed a survey (available in 25 languages) which aims to gather insights from patients, carers, and patient representatives on their experiences, expectations, and concerns regarding the integration of AI technologies into healthcare systems across Europe.

No prior knowledge of AI is required and responses are anonymous. The deadline is 21st August, 2025.